UK’s NICE greenlights Abbott’s CardioMEMS heart failure sensor
The implantable blood pressure sensor will now be available to patients with chronic heart failure through the NHS.
Therapy Area
Pulse Biosciences and MD Anderson to study nPulse for thyroid cancer
Roche gains CE Mark for bacterial vaginosis/candida vaginitis assay
Lunit seeks FDA clearance for breast cancer risk prediction model
Örebro University researchers develop new AI models for dementia
Cordance to advance ultrasound platform trial with new funding
Beacon and Takeda expand neurobiomarker discovery collaboration
Freenome and Roche partner on cancer screening technology for ex-US markets
